4/26/2013

Corning will manufacture a handheld, battery-operated device developed by the FDA to detect fake or substandard malaria drugs. The device will be tested first in Ghana, then in other areas where malaria rates are high and counterfeit drugs are common. The FDA plans to distribute the device in coordination with the NIH, CDC, USAID and other organizations.

Related Summaries